MJPRRS
vaccine has proven itself as a cost-effective new
tool in large numbers of nursery grow - finish pigs
5
strain for broad cross-protection

Veterinarians
are now recommending MJPRRS vaccine for use in nursery-grower
pigs. Over the last few years MJPRRS vaccine has shown
substantial benefits in helping to control PRRS in
sow herds. Recently, its use has been expanded to
include groups of weaned pigs that were at least partially
PRRS PCR positive at weaning. Results from the field
have shown significantly improved health and reduced
death loss. Contact MJ Biologics for more information.
|

MVP Laboratories partners with MJ Biologics
to combat PRRSV
»
MJ
Biologics exhibited at the VIV China Conference on October
20-22, 2008 at the new China International Exhibition Centre
in Beijing, P.R. China
»
Leman Conference 2008 - B.K. Kim, Ph.D. of MJ Biologics gave
a PRRS virus presentation at the conference (click here to
see the presentation!)
»
The Farmer Magazine - Vaccine May Help Erradicate PRRS, July,
2008 (click here to read the article!)
»
Mankato Free Press Article - Mankato Company Develops Hog
Vaccine, May 25, 2008 (click here to read the article!)
»
University of Minnesota Press Release - New Vaccine Provides
Customized Tool for Control and Prevention of PRRS Virus
»
See
our VIV Conference brochure - Chinese version
MANKATO,
MN. (May 23, 2008) — MJ Biologics, in conjunction with
the University of Minnesota, announces a breakthrough in the
control and prevention of porcine reproductive and respiratory
syndrome disease (PRRS), a devastating disease of pigs worldwide.
Research conducted by MJ Biologics and the University has
led to the decoding of the PRRS virus and the development
of a new inactivated vaccine.
Patent-pending
MJPRRS™ technology now offers veterinarians and swine
producers a new tool in the ongoing battle against the PRRS
virus. By breaking the genetic code of the PRRS virus, MJPRRS
technology allows the production of autogenous vaccines that
are tailored to each unique swine production system. This
technology utilizes an innovative method of classifying PRRS
viruses based on their immunological properties, allowing
for the creation of new custom vaccines as a tool against
intra-farm mutations. In addition, the enhanced cross-protection
capability helps to reduce financial losses from new strains
introduced into the farm.
In pregnant sow control studies conducted by independent veterinarians
and the University, the MJPRRS vaccine provided excellent
cross protection against heterologous strains of PRRS virus.
“By using the vaccine in herds with a history of PRRS
virus, we have been able to prevent prenatal losses while
stabilizing the herds and simultaneously protecting the sow
population against clinical disease outbreaks from ‘new’
virus strains entering the herd,” said Dr. Paul Armbrecht
of Lake City Veterinary Service in Lake City, Iowa.
Many
veterinarians and swine producers have already experienced
the value of the MJPRRS vaccine. According to Dr. Mark Fitzsimmons,
recipient of the 2006 Swine Practitioner of the Year, “MJPRRS
technology appears to be one of the biggest breakthroughs
in disease control across the swine industry in the last 10
years. Finally we have some light at the end of the tunnel
in controlling and preventing this devastating disease.”
MJ
Biologics has teamed with U.S.D.A.-licensed companies to produce
MJPRRS autogenous vaccine, which is now available through
licensed veterinarians. For more information on MJPRRS vaccine,
contact MJ Biologics at (507) 385-0299.